Papaverine Sopharma (Papaverine Hydrochloride)

Papaverine Hydrochloride, the active ingredient in Papaverine Sopharma, is a phosphodiesterase inhibitor presented as a sterile injectable solution for intravenous use. It relaxes smooth muscle and dilates blood vessels, helping to manage vascular spasm in adult patients. GNH USA supplies Papaverine Sopharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Papaverine acts as a vasodilator and smooth‑muscle relaxant in several vascular and gastrointestinal conditions. - Coronary artery spasm: alleviates transient coronary constriction and reduces chest pain. - Peripheral vascular disease: improves limb blood flow in patients with arterial insufficiency. - Gastrointestinal spasm: relaxes intestinal smooth muscle to relieve colicky pain. - Erectile dysfunction (off‑label): facilitates penile erection by enhancing blood flow.

Papaverine may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Flushing: transient warmth and redness of the skin. - Hypotension: mild to moderate drop in blood pressure. - Headache: dull or throbbing pain, often positional. - Nausea: mild gastrointestinal upset. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramp‑like discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring intervention. - Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening. - Anaphylactic reaction: sudden allergy with airway compromise. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Seizures: uncommon neurologic events.

When using Papaverine, clinicians should observe several safety measures. - Cardiovascular assessment: evaluate baseline blood pressure and heart function. - Blood pressure monitoring: check regularly during infusion. - Hepatic impairment: use with caution in patients with liver disease. - Hypersensitivity: avoid in individuals with known allergy to papaverine or excipients. - Renal impairment: adjust dosing if significant kidney dysfunction is present. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Papaverine can interact with other agents that affect vascular tone or metabolism.

Major Interactions (Avoid): - Nitrates (e.g., nitroglycerin): additive vasodilation may cause profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe blood pressure drop. - MAO inhibitors: potential for exaggerated cardiovascular effects. - Antihypertensive agents: may potentiate blood pressure lowering. - Other vasodilators: increased risk of circulatory collapse.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory heart rate response. - Calcium channel blockers: additive effect on vascular smooth muscle. - General anesthetics: possible enhanced hypotensive response. - Anticoagulants: monitor for bleeding if vascular integrity is compromised. - CYP450 substrates: papaverine may inhibit metabolism of certain drugs.